A Nutrition and Cancer study says that the herbal extract Zyflamend may reduce the growth of prostate cancer cells by 78 percent. The study also reports that Zyflamend, which is an olive-oil based extract, not only suppresses prostate cancer cell growth, but also causes the cells to self-destruct. The results were attained from lab cultures used in the study.

The study's lead investigator, Dr. Debra L. Bemis of Columbia University College of Physicians and Surgeons tells Reuters Health that "...these results suggest that Zyflamend might have some chemopreventive utility against prostate cancer in men."

According to Bemis, "we are currently conducting a Phase I clinical trial for men with a pre-cancerous lesion of the prostate - prostatic intraepithelial neoplasia - to gain some information as to Zyflamend's potential to prevent or slow... progression to prostate cancer."